Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haojun Chen

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Molecular Pharmaceutics|June 20, 2024
Enhanced Detection of Early Pulmonary Fibrosis Disease Using <sup>68</sup>Ga-FAPI-LM3 PETJianhao Chen, Doudou Luo, Yaqing Dai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2025
[<sup>99m</sup>Tc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical StudyYining Sun, Zhixin Hao, Hannan Gao, et al.
Scientific Reports|February 23, 2024
Assessing peptic ulcer risk with the HAMPROW score in the general Chinese populationBinli Wang, Weitao Yu, Zheyu Zhang, et al.
Molecular Pharmaceutics|June 2, 2022
PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor EffectXuejun Wen, Xueyuan Zeng, Xingxing Cheng, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
FAP-targeted radioligand therapy with <sup>68</sup>Ga/<sup>177</sup>Lu-DOTA-2P(FAPI)<sub>2</sub> enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacyJianhao Chen, Yangfan Zhou, Yizhen Pang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2024
Development of [<sup>177</sup>Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinomaJianhao Chen, Yizhen Pang, Xiyi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Somatostatin receptor imaging with [<sup>68</sup>Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinomaLiang Zhao, Yizhen Pang, Yuhuan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2021
<sup>68</sup>Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancerLiang Zhao, Shanyu Chen, Sijia Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2025
FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic managementWei Guo, Weizhi Xu, Tinghua Meng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Clinical Evaluation of <sup>68</sup>Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α<sub>v</sub>β<sub>3</sub> in Various Cancer TypesLiang Zhao, Xuejun Wen, Weizhi Xu, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Molecular Pharmaceutics|June 20, 2024
Enhanced Detection of Early Pulmonary Fibrosis Disease Using <sup>68</sup>Ga-FAPI-LM3 PETJianhao Chen, Doudou Luo, Yaqing Dai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2025
[<sup>99m</sup>Tc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical StudyYining Sun, Zhixin Hao, Hannan Gao, et al.
Scientific Reports|February 23, 2024
Assessing peptic ulcer risk with the HAMPROW score in the general Chinese populationBinli Wang, Weitao Yu, Zheyu Zhang, et al.
Molecular Pharmaceutics|June 2, 2022
PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor EffectXuejun Wen, Xueyuan Zeng, Xingxing Cheng, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
FAP-targeted radioligand therapy with <sup>68</sup>Ga/<sup>177</sup>Lu-DOTA-2P(FAPI)<sub>2</sub> enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacyJianhao Chen, Yangfan Zhou, Yizhen Pang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2024
Development of [<sup>177</sup>Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinomaJianhao Chen, Yizhen Pang, Xiyi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Somatostatin receptor imaging with [<sup>68</sup>Ga]Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinomaLiang Zhao, Yizhen Pang, Yuhuan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2021
<sup>68</sup>Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancerLiang Zhao, Shanyu Chen, Sijia Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2025
FAP-targeted PET/CT imaging in patients with breast cancer from a prospective bi-center study: insights into diagnosis and clinic managementWei Guo, Weizhi Xu, Tinghua Meng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Clinical Evaluation of <sup>68</sup>Ga-FAPI-RGD for Imaging of Fibroblast Activation Protein and Integrin α<sub>v</sub>β<sub>3</sub> in Various Cancer TypesLiang Zhao, Xuejun Wen, Weizhi Xu, et al.
Pageof 15